Gapping down
In reaction to disappointing earnings/guidance:
- CVNA -6.5%, (also commences 10 mln share follow-on public offering of Class A common stock -- includes 4 mln by selling stockholders), SHW -4.6%, MAS -3.4%, MMM -3%, SAN -2.9%, AMTD -2%, TRV -2%, BIIB -2%, CNC -1.9%, TVTY -1.1%, MLI -1.1%
Other news:
- EPZM -15% (announced that U.S.-based enrollment of new patients into tazemetostat clinical trials is temporarily on hold)
- AGO -4.9% (dips lower in after hours trade after Greenlight Capital's David Einhorn voices concerns at the Sohn conference)
- INCY -4.6% (following FDA advisory committee meeting for baricitinib)
- JOE -3.9% (speculation that JOE will be next Kerrisdale short target)
- CASA -3% (files for 7.35 mln share common stock offering by holders including Chief Executive Officer and other officers and directors; announces partial lock-up release)
Analyst comments:
- HSIC -1.3% (downgraded to Neutral from Buy at Goldman)
- SWKS -0.7% (downgraded to Neutral from Buy at Mizuho)
